1
|
Abazid A, Goller J, Stope MB, Huschitt N, Müller U. [Sudden hoarseness! The unusual case of a thyroid gland tumor]. Chirurgie (Heidelb) 2024; 95:480-483. [PMID: 38600371 DOI: 10.1007/s00104-024-02075-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/11/2024] [Indexed: 04/12/2024]
Affiliation(s)
| | - J Goller
- Evangelisches Waldkrankenhaus Spandau, Berlin, Deutschland
| | - M B Stope
- Universitätsklinikum Bonn, Bonn, Deutschland
| | - N Huschitt
- Bundeswehrkrankenhaus Berlin, Berlin, Deutschland
| | - U Müller
- Bundeswehrkrankenhaus Berlin, Berlin, Deutschland
| |
Collapse
|
2
|
Dejonckheere CS, Layer JP, Nour Y, Layer K, Glasmacher A, Wiegreffe S, Fuhrmann A, Caglayan L, Grau F, Sarria GR, Scafa D, Koch D, Heimann M, Leitzen C, Köksal MA, Röhner F, Müdder T, Dejonckheere E, Schmeel FC, Anzböck T, Lindner K, Bachmann A, Abramian A, Kaiser C, Faridi A, Mustea A, Giordano FA, Stope MB, Schmeel LC. Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial. Clin Transl Radiat Oncol 2024; 44:100699. [PMID: 38021092 PMCID: PMC10654149 DOI: 10.1016/j.ctro.2023.100699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 11/02/2023] [Indexed: 12/01/2023] Open
Abstract
Background and Purpose To investigate the effect of topical non-invasive physical plasma (NIPP), a volatile mix generated out of ambient air, on prevention of acute radiation dermatitis (RD) during and after whole-breast irradiation (WBI). Materials and Methods Lateral and medial breast halves were randomised within each patient to receive either 120 s of NIPP or sham treatment daily during WBI. Standard skin care with urea lotion was applied to the whole breast. Blinded acute skin toxicity was assessed weekly for each breast half separately and included clinician- (CTCAE) and patient-reported (modified RISRAS), and objective (spectrophotometry) assessments. As an additional external control, a comparable standard of care (SoC) patient collective from a previous prospective trial was used. Results Sixty-four patients were included. There were no significant differences between breast halves. Post-hoc comparison with a similar SoC control collective revealed OR = 0.28 (95% CI 0.11-0.76; p = 0.014) for grade ≥ 2 RD upon WBI completion, along with less hyperpigmentation (p < 0.001), oedema (p = 0.020), dry (p < 0.001) and moist desquamation (p = 0.017), pain, itching, and burning (p < 0.001 for each). Tolerability of NIPP was excellent and side effects were not observed. Conclusion Even though there were no differences between intrapatient-randomised breast halves, the overall incidence and severity of acute radiation-induced skin toxicity were considerably lower when compared to a prospectively collected SoC cohort. Our data suggest the potential benefit of NIPP in RD prevention. A randomised trial with a physical control group is warranted to confirm these promising results (DRKS00026225).
Collapse
Affiliation(s)
| | - Julian Philipp Layer
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
- Institute of Experimental Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Younèss Nour
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Katharina Layer
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Andrea Glasmacher
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Shari Wiegreffe
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Arne Fuhrmann
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Lara Caglayan
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Franziska Grau
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | | | - Davide Scafa
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - David Koch
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Martina Heimann
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Christina Leitzen
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Mümtaz Ali Köksal
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Fred Röhner
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Thomas Müdder
- Department of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Egon Dejonckheere
- Faculty of Psychology and Educational Sciences, KU Leuven, 3000 Leuven, Belgium
- Department of Medical and Clinical Psychology, Tilburg School of Social and Behavioural Sciences, 5037 Tilburg, the Netherlands
| | | | - Teresa Anzböck
- Department of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Kira Lindner
- Department of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany
| | - Anne Bachmann
- Department of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany
| | - Alina Abramian
- Department of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany
| | - Christina Kaiser
- Department of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany
| | - Andree Faridi
- Department of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany
| | - Alexander Mustea
- Department of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | - Frank Anton Giordano
- Department of Radiation Oncology, University Medical Center Mannheim, 68167 Mannheim, Germany
| | - Matthias Bernhard Stope
- Department of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany
| | | |
Collapse
|
3
|
Eggers B, Stope MB, Marciniak J, Mustea A, Eick S, Deschner J, Nokhbehsaim M, Kramer FJ. Non-Invasive Physical Plasma Reduces the Inflammatory Response in Microbially Prestimulated Human Gingival Fibroblasts. Int J Mol Sci 2023; 24:16156. [PMID: 38003346 PMCID: PMC10671174 DOI: 10.3390/ijms242216156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2023] [Revised: 11/04/2023] [Accepted: 11/07/2023] [Indexed: 11/26/2023] Open
Abstract
Non-invasive physical plasma (NIPP), an electrically conductive gas, is playing an increasingly important role in medicine due to its antimicrobial and regenerative properties. However, NIPP is not yet well established in dentistry, although it has promising potential, especially for periodontological applications. The aim of the present study was to investigate the effect of NIPP on a commercially available human gingival fibroblast (HGF) cell line and primary HGFs in the presence of periodontitis-associated bacteria. First, primary HGFs from eight patients were characterised by immunofluorescence, and cell numbers were examined by an automatic cell counter over 5 days. Then, HGFs that were preincubated with Fusobacterium nucleatum (F.n.) were treated with NIPP. Afterwards, the IL-6 and IL-8 levels in the cell supernatants were determined by ELISA. In HGFs, F.n. caused a significant increase in IL-6 and IL-8, and this F.n.-induced upregulation of both cytokines was counteracted by NIPP, suggesting a beneficial effect of physical plasma on periodontal cells in a microbial environment. The application of NIPP in periodontal therapy could therefore represent a novel and promising strategy and deserves further investigation.
Collapse
Affiliation(s)
- Benedikt Eggers
- Department of Oral, Maxillofacial and Plastic Surgery, University Hospital Bonn, 53111 Bonn, Germany;
| | - Matthias Bernhard Stope
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, 53127 Bonn, Germany; (M.B.S.); (A.M.)
| | - Jana Marciniak
- Department of Orthodontics, University Hospital Bonn, 53111 Bonn, Germany;
| | - Alexander Mustea
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, 53127 Bonn, Germany; (M.B.S.); (A.M.)
| | - Sigrun Eick
- Department of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland;
| | - James Deschner
- Department of Periodontology and Operative Dentistry, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany;
| | - Marjan Nokhbehsaim
- Section of Experimental Dento-Maxillo-Facial Medicine, University Hospital Bonn, 53111 Bonn, Germany;
| | - Franz-Josef Kramer
- Department of Oral, Maxillofacial and Plastic Surgery, University Hospital Bonn, 53111 Bonn, Germany;
| |
Collapse
|
4
|
Dejonckheere CS, Schmeel LC, Stope MB. Concise review of non-invasive physical plasma as a promising treatment option for radiation injuries of the skin. Wound Repair Regen 2023; 31:415-417. [PMID: 36861202 DOI: 10.1111/wrr.13077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 01/26/2023] [Accepted: 02/10/2023] [Indexed: 03/03/2023]
Abstract
Radiation injury has a complex pathophysiology and can result in long-term impediment of the dermal barrier function. Historically, its treatment has been no different to that of thermal burns and it is not always possible to prevent an unpredictable and uncontrolled extension of the radiation-induced reactions. Non-invasive physical plasma (NIPP), a highly energised gas encompassing a combination of various reactive species, positively affects the key players involved in wound healing and proves to be a promising treatment option for chronic wounds and inflammatory skin disorders. Recent clinical evidence also suggests preliminary efficacy in radiation injury following therapeutic irradiation as a part of cancer therapy. Further research is warranted to also investigate the clinical value of NIPP in the context of unplanned or accidental radiation exposure, either as a topical treatment or possibly as an intraoperative procedure, to potentially improve the dermatological outcome and reduce symptoms in radiation victims.
Collapse
Affiliation(s)
| | | | - Matthias Bernhard Stope
- Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany
| |
Collapse
|
5
|
Abazid A, Gest C, Holstein N, Stope MB, Huschitt N, Hauer T, Badendieck S. [Femoral hernia? Lymph nodes? Appendix? Case presentation of a rarity]. Chirurgie (Heidelb) 2023; 94:164-167. [PMID: 36400964 DOI: 10.1007/s00104-022-01759-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/12/2022] [Indexed: 06/16/2023]
Affiliation(s)
- A Abazid
- Klinik für Allgemein- und Viszeralchirurgie, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115, Berlin, Deutschland.
| | | | | | | | | | | | | |
Collapse
|
6
|
Stope MB. The Raccoon ( Procyon lotor) as a Neozoon in Europe. Animals (Basel) 2023; 13:ani13020273. [PMID: 36670814 PMCID: PMC9854693 DOI: 10.3390/ani13020273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 01/10/2023] [Accepted: 01/11/2023] [Indexed: 01/15/2023] Open
Abstract
The raccoon (Procyon lotor) is a North American half-bear that is present in much of Europe and Asia as a result of both accidental and planned releases. In Europe, raccoons were introduced primarily as a source of fur for the fur industry. In the 1930s, raccoons were released into the wild in Central Europe. At the same time, animals from fur farms and private holdings continued to enter the wild. In the following decades, the raccoon spread over large parts of Europe. In addition to the invasive spread of the Central European initial population, individual releases of raccoons occurred frequently, mainly in Southern Europe. The high adaptability of the raccoon favors its expansion into new habitats. It has a high reproductive rate, is very mobile, and encounters few predators in Europe. Raccoons have recently become a topic of interest when large raccoon populations have colonized suburban and urban areas. Despite the proximity of raccoons and humans, however, there have been hardly any conflicts to date, unlike in North America. A significant negative impact on the native fauna has been suspected but not proven. Raccoons have been identified as vectors of zoonotic diseases. Nevertheless, monitoring of the increasing numbers of raccoons in Europe seems advisable.
Collapse
Affiliation(s)
- Matthias Bernhard Stope
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany
| |
Collapse
|
7
|
Weimer J, Hüttmann M, Nusilati A, Andreas S, Röseler J, Tribian N, Rogmans C, Stope MB, Dahl E, Mustea A, Stickeler E, Hedemann N, Flörkemeier I, Tiemann K, Magadeeva S, Dempfle A, Arnold N, Maass N, Bauerschlag D. Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swab. J Cell Mol Med 2023; 27:379-391. [PMID: 36625073 PMCID: PMC9889703 DOI: 10.1111/jcmm.17658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 10/19/2022] [Accepted: 12/10/2022] [Indexed: 01/11/2023] Open
Abstract
Endometrial cancer (EC) is the most common gynaecological malignancy with increasing incidence in developed countries. As gold standard, hysteroscopy confirms only 30% of suspected ECs. The detection of EC cells in the vagina by fluorescence in situ hybridization (FISH) after a smear test could reduce invasive procedures in the future. Using array-based comparative genome hybridization (aCGH) on 65 endometrial carcinomas, most frequently imbalanced regions of the tumour genome were identified. Bacterial artificial chromosomes were used to generate FISH-probes homologue to these human regions. The FISH test was hybridized on swabs specimens collected from the vaginal cavity. Samples from six patients without EC were selected as a negative control and on 13 patients with known EC as a positive control. To distinguish between benign and EC cases, the cut-off value has been defined. A first validation of this EC-FISH Test was performed with swabs from 41 patients with suspected EC. The most common genomic imbalances in EC are around the CTNNB1, FBXW7 and APC genes. The cut-off is defined at 32% of analysed cells without diploid signal pattern. This differs significantly between the positive and negative controls (p < 0.001). In a first validation cohort of 41 patients with suspected EC, the EC-FISH Test distinguishes patients with and without EC with a sensitivity of 91% and a specificity of 83%. The negative predictive value is 96%. This is the first report of a non-invasive EC-FISH Test to predict EC in women with suspected EC.
Collapse
Affiliation(s)
- Jörg Weimer
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Martje Hüttmann
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Asiyan Nusilati
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Svenja Andreas
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Jona Röseler
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Nils Tribian
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Christoph Rogmans
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | | | - Edgar Dahl
- Institute of PathologyMedical Faculty of RWTH Aachen UniversityAachenGermany
| | - Alexander Mustea
- Department of Gynecology and Gynecological OncologyUniversity Hospital BonnBonnGermany
| | - Elmar Stickeler
- Department of GynecologyUniversity Medical Center RWTH AachenAachenGermany
| | - Nina Hedemann
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Inken Flörkemeier
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | | | - Svetlana Magadeeva
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Astrid Dempfle
- Institute of Medical Informatics and StatisticsKiel University and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Norbert Arnold
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Nicolai Maass
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| | - Dirk Bauerschlag
- Department of Gynecology and ObstetricsChristian‐Albrechts‐University Kiel and University Medical Center Schleswig‐Holstein Campus KielKielGermany
| |
Collapse
|
8
|
Eggers B, Stope MB, Marciniak J, Götz W, Mustea A, Deschner J, Nokhbehsaim M, Kramer FJ. Non-Invasive Physical Plasma Generated by a Medical Argon Plasma Device Induces the Expression of Regenerative Factors in Human Gingival Keratinocytes, Fibroblasts, and Tissue Biopsies. Biomedicines 2022; 10:biomedicines10040889. [PMID: 35453639 PMCID: PMC9028866 DOI: 10.3390/biomedicines10040889] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 04/07/2022] [Accepted: 04/11/2022] [Indexed: 02/06/2023] Open
Abstract
After oral surgery, intraoral wound healing and tissue regeneration is an important factor for the success of the entire therapy. In recent years, non-invasive medical plasma (NIPP) has been shown to accelerate wound healing, which would be particularly beneficial for patients with wound healing disorders. Since the application of NIPP in dentistry has not been sufficiently understood, the aim of the present study was to investigate the effect of a medical argon plasma device on gingival cells. Human gingival fibroblasts, keratinocytes, and tissue biopsies were treated with NIPP for different durations. Crucial markers associated with wound healing were examined at the mRNA and protein levels by real-time PCR, ELISA and immunohistochemistry. NIPP treatment led to an increase in Ki67 and MMP1 at mRNA and protein levels. NIPP application lasting longer than 60 s resulted in an increase in apoptotic genes at mRNA level and superficial damage to the epithelium in the tissue biopsies. Overall, our experimental setup demonstrated that NIPP application times of 30 s were most suitable for the treatment of gingival cells and tissue biopsies. Our study provides evidence for potential use of NIPP in dentistry, which would be a promising treatment option for oral surgery.
Collapse
Affiliation(s)
- Benedikt Eggers
- Department of Oral, Maxillofacial and Plastic Surgery, University Hospital Bonn, 53111 Bonn, Germany;
- Correspondence: ; Tel.: +49-0228-287-22407
| | - Matthias Bernhard Stope
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, 53127 Bonn, Germany; (M.B.S.); (A.M.)
| | - Jana Marciniak
- Department of Orthodontics, University Hospital Bonn, 53111 Bonn, Germany; (J.M.); (W.G.)
| | - Werner Götz
- Department of Orthodontics, University Hospital Bonn, 53111 Bonn, Germany; (J.M.); (W.G.)
| | - Alexander Mustea
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, 53127 Bonn, Germany; (M.B.S.); (A.M.)
| | - James Deschner
- Department of Periodontology and Operative Dentistry, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany;
| | - Marjan Nokhbehsaim
- Section of Experimental Dento-Maxillo-Facial Medicine, University Hospital Bonn, 53111 Bonn, Germany;
| | - Franz-Josef Kramer
- Department of Oral, Maxillofacial and Plastic Surgery, University Hospital Bonn, 53111 Bonn, Germany;
| |
Collapse
|
9
|
Recker F, Dohmen S, Egger EK, Stope MB, Dimitrova D, Könsgen D, Ritter M, Sehouli J, Bondio MG, Mustea A. Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patients. Arch Gynecol Obstet 2021; 305:389-395. [PMID: 34705116 PMCID: PMC8549413 DOI: 10.1007/s00404-021-06280-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2021] [Accepted: 10/11/2021] [Indexed: 11/12/2022]
Abstract
Purpose The pandemic SARS-CoV-2 poses new and unprecedented challenges for health care systems on a national and global level. Although the current situation has been going on for more than 1 year, there is limited data on the impact of the pandemic on general hospital and medical practice care. This survey captures the perspective of patients with gynaecological diseases of this impact. Methods Using a paper-based questionnaire, 327 patients were asked about medical care and their experiences during the pandemic at the University Hospital Bonn and the University Hospital Charité Berlin. The study was performed from the 1st June to 30th September 2020. Results A total of 327 patients participated in the study: 156 stated to have been tested for coronavirus, and 1 patient reported a positive test. 41.3% of the patients felt insecure about the current situation, 30.4% were concerned about the risk of infection during the hospital stay. The pandemic-specific measures in hospitals and medical practices unsettled 6.8% of patients. 18.1% of patients feared that their gynaecological disease would not be treated adequately due to the pandemic. 55.7% of patients reported that their confidence in their physicians has increased during the pandemic. Conclusion The results show that patients’ confidence in the healthcare system and the physicians acting significantly increased during the COVID-19 crisis. Transparent and comprehensive information policy regarding actions and restrictions within the COVID-19 crisis eases patients concerns and improves patients’ confidence in their physicians, which is crucial for a successful treatment’s outcome.
Collapse
Affiliation(s)
- F Recker
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany.
| | - S Dohmen
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany
| | - E K Egger
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany
| | - M B Stope
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany
| | - D Dimitrova
- Department for Gynecology with Centre for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany
| | - D Könsgen
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany
| | - M Ritter
- Department of Urology, University Hospital Bonn, Bonn, Germany
| | - J Sehouli
- Department for Gynecology with Centre for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany
| | - M Gadebusch Bondio
- Institute of Medical Humanities, University Hospital Bonn, Bonn, Germany
| | - A Mustea
- Department for Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany
| |
Collapse
|
10
|
Abazid A, Holstein N, Machemehl T, Stope MB, Hauer T. [The zebra among the diverticular diseases]. Chirurg 2021; 92:374-376. [PMID: 32767017 DOI: 10.1007/s00104-020-01261-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- A Abazid
- Klinik für Allgemein- und Viszeralchirurgie, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115, Berlin, Deutschland.
| | - N Holstein
- Klinik für Allgemein- und Viszeralchirurgie, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115, Berlin, Deutschland
| | - T Machemehl
- Klinik für Allgemein- und Viszeralchirurgie, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115, Berlin, Deutschland
| | - M B Stope
- Klinik für Gynäkologie und Gynäkologische Onkologie, Universitätsklinikum Bonn, Bonn, Deutschland
| | - T Hauer
- Klinik für Allgemein- und Viszeralchirurgie, Bundeswehrkrankenhaus Berlin, Scharnhorststr. 13, 10115, Berlin, Deutschland
| |
Collapse
|
11
|
Idda T, Bonas C, Hoffmann J, Bertram J, Quinete N, Schettgen T, Fietkau K, Esser A, Stope MB, Leijs MM, Baron JM, Kraus T, Voigt A, Ziegler P. Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster. Sci Rep 2020; 10:21587. [PMID: 33299007 PMCID: PMC7726022 DOI: 10.1038/s41598-020-78405-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Accepted: 11/20/2020] [Indexed: 01/26/2023] Open
Abstract
Degradation of polychlorinated biphenyls (PCBs) is initiated by cytochrome P450 (CYP) enzymes and includes PCB oxidation to OH-metabolites, which often display a higher toxicity than their parental compounds. In search of an animal model reflecting PCB metabolism and toxicity, we tested Drosophila melanogaster, a well-known model system for genetics and human disease. Feeding Drosophila with lower chlorinated (LC) PCB congeners 28, 52 or 101 resulted in the detection of a human-like pattern of respective OH-metabolites in fly lysates. Feeding flies high PCB 28 concentrations caused lethality. Thus we silenced selected CYPs via RNA interference and analyzed the effect on PCB 28-derived metabolite formation by assaying 3-OH-2',4,4'-trichlorobiphenyl (3-OHCB 28) and 3'-OH-4',4,6'-trichlorobiphenyl (3'-OHCB 28) in fly lysates. We identified several drosophila CYPs (dCYPs) whose knockdown reduced PCB 28-derived OH-metabolites and suppressed PCB 28 induced lethality including dCYP1A2. Following in vitro analysis using a liver-like CYP-cocktail, containing human orthologues of dCYP1A2, we confirm human CYP1A2 as a PCB 28 metabolizing enzyme. PCB 28-induced mortality in flies was accompanied by locomotor impairment, a common phenotype of neurodegenerative disorders. Along this line, we show PCB 28-initiated caspase activation in differentiated fly neurons. This suggested the loss of neurons through apoptosis. Our findings in flies are congruent with observation in human exposed to high PCB levels. In plasma samples of PCB exposed humans, levels of the neurofilament light chain increase after LC-PCB exposure, indicating neuronal damage. In summary our findings demonstrate parallels between Drosophila and the human systems with respect to CYP mediated metabolism and PCB mediated neurotoxicity.
Collapse
Affiliation(s)
- T Idda
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - C Bonas
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - J Hoffmann
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - J Bertram
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - N Quinete
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
- Department of Chemistry and Biochemistry, Florida International University Florida, Florida, USA
| | - T Schettgen
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - K Fietkau
- Department of Dermatology and Allergology, RWTH Aachen University, 52074, Aachen, Germany
| | - A Esser
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - M B Stope
- Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany
| | - M M Leijs
- Department of Dermatology and Allergology, RWTH Aachen University, 52074, Aachen, Germany
| | - J M Baron
- Department of Dermatology and Allergology, RWTH Aachen University, 52074, Aachen, Germany
| | - T Kraus
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany
| | - A Voigt
- Department of Neurology, University Medical Center, RWTH Aachen University, 52074, Aachen, Germany
- JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH, RWTH Aachen University, 52074, Aachen, Germany
| | - P Ziegler
- Institute for Occupational, Social and Environmental Medicine, RWTH Aachen University, Aachen, Germany.
| |
Collapse
|
12
|
Abstract
Cold atmospheric plasma (CAP) is a highly reactive ionized physical state consisting of electrically charged particles, radicals and photons as well as electromagnetic radiation. Due to the high energy and reactivity of plasma components, physical plasmas are also referred to as the 4th aggregate state. In biological systems, CAP promotes antimicrobial, immunomodulatory, anti-inflammatory, and wound-healing effects. Moreover, CAP bears antineoplastic properties which may be applied as a potential intraoperative option in the treatment of wound and resection margins during surgery of urological tumors. Some properties such as the penetration depth in various biological tissues, the effect on physiological healthy tissue, and the molecular mode of action regarding signalling and effector pathways are the subject of further investigation. CAP treatment effectively attenuates malignant cell growth. As an intraoperative application, CAP may represent a promising option particularly for the treatment of tissue regions that are close to critical structures (e. g., nerves, adjacent organs). The present review article summarizes the current status of CAP-related studies in the field of urological oncology.
Collapse
Affiliation(s)
- N Gelbrich
- Klinik und Poliklinik für Urologie, Universitätsmedizin Greifswald, 17475, Greifswald, Deutschland.
| | - M B Stope
- Klinik und Poliklinik für Urologie, Universitätsmedizin Greifswald, 17475, Greifswald, Deutschland
| | - M Burchardt
- Klinik und Poliklinik für Urologie, Universitätsmedizin Greifswald, 17475, Greifswald, Deutschland
| |
Collapse
|
13
|
Abstract
Religion, which is one of the most important sources of human identity, has so far hardly been taken into account in the clinic. In the largely secularized society of Germany, this has played a highly subordinate role. Currently, however, the development towards a multireligious society is emerging, which will also be reflected in everyday medical care. Disease and mortality in patients can affect different cultural-religious spheres. Although distinction between cultural and religious aspects is possible, it is not necessary for clinical practice. In the situation of oncological therapy, questions may arise which must be answered differently in the religions Christianity, Judaism and Islam and which should be taken into account when selecting therapy. The consideration of cultural-religious rules can intensify the patient's acceptance, but it can also impair it in case of disregard. Such peculiarities can be the separation into male and female spheres or the restriction of certain auxiliary substances or drugs (blood products, narcotics). Kübler-Ross's phase model is suitable for determining where cultural-religious sensitivities should be taken into account in the phases of disease and how cultural-religious offerings can benefit the course of therapy. Due to large individual, regional, cultural and confessional differences, no systematic catalogue of procedures can be provided here. However, knowledge of such differences, more sensitive interaction with patients and their families and cooperation with hospital pastors can strengthen the relationship of trust between doctor and patient and thus improve the conditions for successful oncological therapy. These aspects should not be underestimated when treating people of other faiths in Germany's secular society.
Collapse
Affiliation(s)
- J Fischer
- IB GIS Internationaler Bund - Gesellschaft für interdisziplinäre Studien, Hauptstätter Straße 119-121, 70178, Stuttgart, Deutschland.
| | - M B Stope
- Klinik und Poliklinik für Urologie, Universitätsmedizin Greifswald, Greifswald, Deutschland
| | - D Gümbel
- Klinik und Poliklinik für Unfall‑, Wiederherstellungschirurgie und Rehabilitative Medizin, Universitätsmedizin Greifswald, Greifswald, Deutschland
| | - O Hakenberg
- Urologische Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Rostock, Deutschland
| | - M Burchardt
- Klinik und Poliklinik für Urologie, Universitätsmedizin Greifswald, Greifswald, Deutschland
| | - D L Dräger
- Urologische Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Rostock, Deutschland
| |
Collapse
|
14
|
Weimer J, Nusilati A, Tiemann K, Stope MB, Mustea A, Karow D, Hamann S, Hedemann N, Flörkemeier I, Röcken C, Bauerschlag D, Arnold N, Maass N. Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1675449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- J Weimer
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - A Nusilati
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - K Tiemann
- Institute for Hematopathology Hamburg, Hamburg, Germany
| | - MB Stope
- Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany
| | - A Mustea
- Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany
| | - D Karow
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - S Hamann
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Hedemann
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - I Flörkemeier
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - C Röcken
- Deptment of Pathology, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - D Bauerschlag
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Arnold
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Maass
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| |
Collapse
|
15
|
Nusilati A, Weimer J, Tiemann K, Stope MB, Mustea A, Karow D, Hamann S, Hedemann N, Flörkemeier I, Röcken C, Bauerschlag D, Arnold N, Maass N. Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV). Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1675450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- A Nusilati
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - J Weimer
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - K Tiemann
- Institute for Hematopathology Hamburg, Hamburg, Germany
| | - MB Stope
- Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany
| | - A Mustea
- Department of Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany
| | - D Karow
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - S Hamann
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Hedemann
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - I Flörkemeier
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - C Röcken
- Department. of Pathology, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - D Bauerschlag
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Arnold
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| | - N Maass
- Clinic of Gynecology and Obstetrics, Oncology Laboratory; University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel; Germany
| |
Collapse
|
16
|
Stope MB, Hettenbach D, Paditz M, Diesing K, Klinkmann G, Burchardt M, Koensgen D, Mustea A. The role of the tumor suppressor microRNA-1 in ovarian cancer. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Weiss M, Stope MB, Klinkmann G, Könsgen D, Brucker S, Wallwiener D, Burchardt M, Mustea A. Induction and secretion of pro-oncogenic heat shock protein 27 in ovarian cancer cells. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
18
|
Kahle NA, Joffroy C, Popp SL, Knabbe C, Stope MB. Furin cleavage of bacterial expressed glutathione-S-transferase-pro-transforming growth factor beta1 fusion protein in vitro. Protein Pept Lett 2009; 17:416-8. [PMID: 19594430 DOI: 10.2174/092986610790963609] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2010] [Accepted: 02/16/2010] [Indexed: 11/22/2022]
Abstract
To investigate the processing of transforming growth factor beta1 (TGFbeta1) pro-protein by furin protease we expressed a GST-pro-TGFbeta1 fusion protein in bacteria. Analysis of the furin digestion pattern revealed the liberation of 12.5 kDa TGFbeta1 monomers. There was no evidence for cleavage of an alternative furin site within the pro-protein.
Collapse
Affiliation(s)
- N A Kahle
- Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Robert Bosch Hospital, 70376 Stuttgart, Germany
| | | | | | | | | |
Collapse
|
19
|
Stope MB, Becher D, Hammer E, Schauer F. Cometabolic ring fission of dibenzofuran by Gram-negative and Gram-positive biphenyl-utilizing bacteria. Appl Microbiol Biotechnol 2002; 59:62-7. [PMID: 12073133 DOI: 10.1007/s00253-002-0979-7] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2001] [Revised: 02/12/2002] [Accepted: 02/15/2002] [Indexed: 10/27/2022]
Abstract
Thirty-five strains of soil bacteria were grown with biphenyl (BP) and tested for their capacity to cooxidize dibenzofuran (DBF). During metabolism of DBF, the culture medium of 17 strains changed from colorless to orange, indicating a meta-cleavage pathway of DBF degradation. The ring cleavage product of these isolates was shown to be 2-hydroxy-4-(3'-oxo-3' H-benzofuran-2'-yliden)but-2-enoic acid (HOBB). The strain SBUG 271, studied in detail and identified as Rhodococcus erythropolis, degraded DBF via 1,2-dihydroxydibenzofuran. The ensuing meta-cleavage yielded HOBB and salicylic acid. In addition, the four monohydroxylated monomers of DBF and two metabolites, which were not further characterized, were detected. Thus, our results demonstrate that the metabolic mechanism involves lateral dioxygenation of DBF followed by meta-cleavage and occurs in Gram-negative as well as in Gram-positive BP-degrading bacteria.
Collapse
Affiliation(s)
- M B Stope
- Institute of Molecular Biology, Friedrich-Loeffler-Institutes, Federal Research Centre for Virus Diseases of Animals, Boddenblick 5a, 17498 Insel Riems, Germany.
| | | | | | | |
Collapse
|
20
|
Stope MB, Karger A, Schmidt U, Buchholz UJ. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins. J Virol 2001; 75:9367-77. [PMID: 11533200 PMCID: PMC114505 DOI: 10.1128/jvi.75.19.9367-9377.2001] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Chimeric bovine respiratory syncytial viruses (BRSV) expressing glycoproteins of bovine parainfluenza virus type 3 (BPIV-3) instead of BRSV glycoproteins were generated from cDNA. In the BRSV antigenome cDNA, the open reading frames of the major BRSV glycoproteins, attachment protein G and fusion protein F, were replaced individually or together by those of the BPIV-3 hemagglutinin-neuraminidase (HN) and/or fusion (F) glycoproteins. Recombinant virus could not be recovered from cDNA when the BRSV F open reading frame was replaced by the BPIV-3 F open reading frame. However, cDNA recovery of the chimeric virus rBRSV-HNF, with both glycoproteins replaced simultaneously, and of the chimeric virus rBRSV-HN, with the BRSV G protein replaced by BPIV-3 HN, was successful. The replication rates of both chimeras were similar to that of standard rBRSV. Moreover, rBRSV-HNF was neutralized by antibodies specific for BPIV-3, but not by antibodies specific to BRSV, demonstrating that the BRSV glycoproteins can be functionally replaced by BPIV-3 glycoproteins. In contrast, rBRSV-HN was neutralized by BRSV-specific antisera, but not by BPIV-3 specific sera, showing that infection of rBRSV-HN is mediated by BRSV F. Hemadsorption of cells infected with rBRSV-HNF and rBRSV-HN proved that BPIV-3 HN protein expressed by rBRSV is functional. Colocalization of the BPIV-3 glycoproteins with BRSV M protein was demonstrated by confocal laser scan microscopy. Moreover, protein analysis revealed that the BPIV-3 glycoproteins were present in chimeric virions. Taken together, these data indicate that the heterologous glycoproteins were not only expressed but were incorporated into the envelope of recombinant BRSV. Thus, the envelope glycoproteins derived from a member of the Respirovirus genus can together functionally replace their homologs in a Pneumovirus background.
Collapse
Affiliation(s)
- M B Stope
- Institute of Molecular Biology, Friedrich-Loeffler-Institutes, Federal Research Centre for Virus Diseases of Animals, D-17498 Insel Riems, Germany
| | | | | | | |
Collapse
|